Mesenchymal stem cells induce an inflammatory response after intravenous infusion

Area of Science:

• Immunology
• Cell Biology
• Regenerative Medicine

Background:

• Mesenchymal stem cells (MSCs) exhibit immunosuppressive properties in vitro.
• MSCs are investigated for treating autoimmune diseases and preventing organ transplant rejection.
• The precise in vivo immunomodulatory mechanisms of MSCs remain unclear.

Purpose of the Study:

• To investigate the in vivo immunomodulatory mechanisms of MSCs.
• To characterize the host immune response following MSC infusion in mice.

Main Methods:

• Intravenous infusion of green fluorescent protein (GFP)-labeled MSCs into C57BL/6 recipient mice.
• Analysis of MSC homing to lung and liver tissues using fluorescence.
• Measurement of inflammatory markers (cytokines, chemokines) via mRNA and protein expression.
• Assessment of immune response modulation using lipopolysaccharide challenge.

Main Results:

• MSCs preferentially homed to the lungs, inducing a localized inflammatory response with increased pro-inflammatory mediators (MCP1, IL1-β, TNF-α) and macrophages.
• Systemic immune activation was observed, indicated by increased serum levels of IL6, CXCL1, and MCP1.
• Liver tissue showed transient increases in MCP1 and TNF-α without MSC detection.
• A subsequent reduction in inflammatory reactivity to lipopolysaccharide was noted 3 days post-MSC infusion.

Conclusions:

• MSC infusion initiates a transient inflammatory response, contributing to their observed in vivo immunomodulatory effects.
• This initial inflammation is followed by a period of dampened immune reactivity, suggesting a biphasic mechanism of action.
• Understanding these mechanisms is crucial for optimizing MSC-based therapies.